mAbs bulk harvest release testing is a critical step in ensuring the safety and efficacy of monoclonal antibody (mAb) therapeutics. It involves a series of tests to verify the identity, potency, purity, and safety of the harvested mAbs before they are used in clinical trials or treatment.
The tests may include protein concentration, purity, aggregation, charge heterogeneity, glycosylation, and identity assays, as well as endotoxin, mycoplasma, and virus clearance validations. The release criteria may vary depending on the type of mAb, the source, the manufacturing process, and the intended use.
mAbs bulk harvest release testing is important not only to meet regulatory requirements but also to ensure the quality and consistency of the product and minimize the risk of adverse events or treatment failure. The testing must be performed by qualified personnel using validated methods and equipment, and the results must be documented and reviewed by multiple parties to ensure accuracy and completeness.
At ALL Chemistry Inc., we offer a comprehensive range of mAbs bulk harvest release testing services to meet your specific needs. Our state-of-the-art facilities and experienced team of scientists use advanced technologies and validated methods to provide accurate, reliable, and timely results. We also offer customized testing protocols and support to help you achieve your development and commercialization goals.
Our mAbs bulk harvest release testing services include:
Protein concentration and purity assays: We use various methods, such as UV spectrophotometry, HPLC, and capillary electrophoresis, to accurately quantify and assess the purity of your harvested mAbs.
Aggregation and charge heterogeneity assays: We use size-exclusion chromatography, dynamic light scattering, and ion-exchange chromatography to detect and quantify the levels of mAb aggregates and charge variants, which can affect the safety and efficacy of the product.
Glycosylation analysis: We use mass spectrometry and other techniques to analyze the glycosylation patterns of your mAbs, which can affect their pharmacokinetics and immunogenicity.
Identity and characterization assays: We use various methods, such as ELISA, SDS-PAGE, and Western blotting, to confirm the identity and quality of your harvested mAbs.
Endotoxin, mycoplasma, and virus clearance validations: We perform rigorous testing to ensure the absence of bacteria, fungi, mycoplasma, and viruses in your harvested mAbs, which can pose significant risks to patient safety.
At ALL Chemistry Inc., we are committed to providing you with high-quality, reliable, and cost-effective mAbs bulk harvest release testing services. Contact us today to learn more about how we can support your success in the mAb therapeutics market.
+1 609 531 0668
STE 104 Marlton , NJ 08053, USA